Trials / Completed
CompletedNCT00333918
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
Efficacy and Safety Study of Topical Bromfenac Ophthalmic Solution vs. Placebo for Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 522 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment of ocular inflammation and pain in subjects who undergo cataract extraction and intraocular lens implantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bromfenac ophthalmic solution | |
| DRUG | placebo comparator |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2006-06-06
- Last updated
- 2013-02-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00333918. Inclusion in this directory is not an endorsement.